Literature DB >> 6767512

Correlation between fibrinogen binding to human platelets and platelet aggregability.

E I Peerschke, M B Zucker, R A Grant, J J Egan, M M Johnson.   

Abstract

Fibrinogen is essential for aggregating platelets with adenosine diphosphate (ADP) and was recently shown to bind to platelets stimulated with ADP. The present work confirms the specific and saturable nature of the platelet-fibrinogen interaction. Binding of 125iodine-labeled fibrinogen to human gel-filtered platelts was maximal at 1 min, and the receptors were saturated when the fibrinogen concentration in the suspending medium approached 0.8 mg/ml. Assuming that one fibrinogen molecule interacts with a single receptor, experiments with 9 normal donors revealed the presence of 12,896 +/- 2456 receptors per platelet. Much of the bound material dissociated from platelets after incubation with apyrase or EDTA. Binding was markedly inhibited at pH 6.5, in the presence of EDTA, and with platelets from 3 thrombasthenic patients but not with those from a patient with the Bernard-Soulier syndrome. Fibrinogen binding was also virtually absent with platelets that had been incubated with EDTA for 8 min at 37 degrees C and pH 7.8. These platelets could not aggregate when mixed with ADP and adequate CaCl2 and fibrinogen, although they could still change their shape. Thus, ADP-induced binding of fibrinogen correlates with platelet aggregability.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6767512

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  55 in total

1.  Role of extracellular ionized calcium in the in vitro assessment of GPIIb/IIIa receptor antagonists.

Authors:  S S Rebello; J Huang; J D Faul; B R Lucchesi
Journal:  J Thromb Thrombolysis       Date:  2000-01       Impact factor: 2.300

2.  Platelet morphologic changes and fibrinogen receptor localization. Initial responses in ADP-activated human platelets.

Authors:  M E Hensler; M Frojmovic; R G Taylor; R R Hantgan; J C Lewis
Journal:  Am J Pathol       Date:  1992-09       Impact factor: 4.307

Review 3.  The human platelet fibrinogen receptor: clinical and therapeutic significance.

Authors:  M Cahill; R Mistry; D B Barnett
Journal:  Br J Clin Pharmacol       Date:  1992-01       Impact factor: 4.335

4.  Platelet aggregation is inhibited by phycolectins.

Authors:  K Matsubara; H Sumi; K Hori
Journal:  Experientia       Date:  1996-06-15

5.  The inhibition of human platelet function by ganodermic acids.

Authors:  C N Wang; J C Chen; M S Shiao; C T Wang
Journal:  Biochem J       Date:  1991-07-01       Impact factor: 3.857

6.  Protein kinase C and cyclic AMP regulate reversible exposure of binding sites for fibrinogen on the glycoprotein IIB-IIIA complex of human platelets.

Authors:  G van Willigen; J W Akkerman
Journal:  Biochem J       Date:  1991-01-01       Impact factor: 3.857

7.  Blood platelet kinetics and platelet transfusion.

Authors:  Richard H Aster
Journal:  J Clin Invest       Date:  2013-11-01       Impact factor: 14.808

8.  Platelet proteome analysis reveals integrin-dependent aggregation defects in patients with myelodysplastic syndromes.

Authors:  Julia Fröbel; Ron-Patrick Cadeddu; Sonja Hartwig; Ingmar Bruns; Christian M Wilk; Andrea Kündgen; Johannes C Fischer; Thomas Schroeder; Ulrich G Steidl; Ulrich Germing; Stefan Lehr; Rainer Haas; Akos Czibere
Journal:  Mol Cell Proteomics       Date:  2013-02-04       Impact factor: 5.911

9.  Inhibition of fibrinogen binding to human platelets by the tetrapeptide glycyl-L-prolyl-L-arginyl-L-proline.

Authors:  E F Plow; G Marguerie
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

Review 10.  Characteristics of an ADP receptor mediating platelet activation.

Authors:  R W Colman; W R Figures
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.